問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberTMC278-TiDP6-C209

2008-05-31 - 2011-03-31

Phase III

Terminated4

  • Trial Applicant

    Johnson & Johnson

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator Hsi-Hsun Lin Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 李欣純 Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator CHIEN-CHING HUNG Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 王永衛 Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    20 participants

  • Global

    680 participants